ResearchForecast

  The General Anesthesia Drugs Market is anticipated to reach a value of US$ 4.7 billion by the end of 2022 and to grow at a CAGR of 3.4% to US$ 6.7 billion by 2032. Propofol is the most popular drug class right now, with a market share of about 25.6% in 2021, according to a recent study by Future Market Insights. Gain complete access to the report @ https://www.futuremarketinsights.com/reports/general-anesthesia-drugs-market Increasing geriatric population coupled with rising incidences of chronic illnesses have resulted in a surge in surgeries. With an increasing elderly population, a greater number of surgeries are conducted resulting in a high demand for anesthesia drugs. Furthermore, the healthcare expenditure is rising in developing and developed countries. Since, anesthesia is usually covered by health insurance for all medical procedures, the out-of-pocket cost for anesthesia for patients with medical insurance is around 10% to 50%. Hence, health insurance is advantage...

  The General Anesthesia Drugs Market is predicted to be worth US$ 4.7 billion by the end of 2022, and to grow at a CAGR of 3.4% to be worth US$ 6.7 billion by the end of 2032. According to a new analysis by Future Market Insights, the Propofol medication class will top the global market with a share of approximately 25.6% in 2021. Get Full Access: https://www.futuremarketinsights.com/reports/general-anesthesia-drugs-market “Tech advancements in drug delivery apparatus, research on patient monitoring devices, and targeted drugs for patients during and after the use of anesthesia, and reduction of side effects from modern anesthetic drugs are providing impetus to growth of the general anesthesia drugs market,” says the FMI analyst. General Anesthesia Drugs Market – Key Takeaways Propofol is a highly popular general anesthesia drug, aided by low risk of side effects. Injectables remain the common general anesthesia drug delivery method, owing to ...